PG: the thesis broke
The thesis only matters if the evidence can change it.
What happened
P&G reported 1% fiscal-year organic sales growth, 1% core EPS growth, and a 100-basis-point decline in reported gross margin to 50.2% for fiscal 2026.
What changed
P&G's fiscal-year 2026 results break the reviewed public operating-resilience thesis: organic sales growth slowed to 1% versus the 2% floor, core EPS still grew 1%, and reported GAAP gross margin declined 100 basis points versus the 50-basis-point maximum.
Why it matters
Profit growth remained positive, but demand growth fell below the reviewed floor and reported GAAP margin deterioration exceeded the explicit invalidation threshold.
Long-term lens
One factor strengthens, one weakens, and the reported GAAP margin invalidation breaks the publisher-owned public thesis; fiscal 2027 execution must rebuild both organic growth and margin resilience.
Why the thesis changed
Core EPS growth remains positive, but organic sales growth weakened below its floor and the 100-basis-point reported GAAP gross-margin decline breaks the reviewed public thesis.
What remains uncertain
Foreign exchange, restructuring, portfolio changes, pricing, mix, commodities, tariffs, and planned reinvestment may affect the pace and composition of fiscal 2027 recovery.
What to watch next
P&G's fiscal-year 2027 first-quarter organic-sales, core-EPS, and reported gross-margin results.
Sources
Next step: Read the evidence and the next test for the thesis.
Put the evidence in your own context
Track your thesis, inspect the evidence, and see what changes over time.
Start your thesis with TickerTrac